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In the elderly, cigarette smoking has been related to reduced cognitive performance and moderate alcohol
consumption to increased cognitive performance. It is not clear whether these associations also exist in middle
age. The authors examined these relations in a population-based cohort study of 1,927 randomly selected,
predominantly middle-aged subjects aged 45–70 years at the time of cognitive testing and living in the
Netherlands. From 1995 until 2000, an extensive cognitive battery was administered, and compound scores were
calculated. Risk factors had been assessed approximately 5 years previously. Multiple linear regression analyses
(in which one unit of the cognitive score = one standard deviation) showed that, after the authors adjusted for
age, sex, education, alcohol consumption, and cardiovascular risk factors, current smokers had reduced
psychomotor speed (beta = –0.159, 95% confidence interval: –0.071, –0.244; p = 0.0003) and reduced cognitive
flexibility (beta = –0.133, 95% confidence interval: –0.035, –0.230; p = 0.008) compared with never smokers. This
effect was similar to that of being approximately 4 years older. Alcohol consumption was related to increased
speed and better flexibility, especially among women who drank 1–4 alcoholic beverages a day. In conclusion,
among middle-aged subjects, current smoking was inversely and alcohol consumption positively related to
psychomotor speed and cognitive flexibility. This finding suggests that actions to prevent cognitive decline can
be taken in middle age.
age factors; age groups; alcohol drinking; cognition; cohort studies; middle age; psychomotor performance; 
smoking
Abbreviations: HDL, high density lipoprotein; MORGEN, Monitoring Project on Cardiovascular Disease Risk Factors.
Few studies have examined risk factors for cognitive
decline in middle-aged subjects. A recent report showed that
a preclinical or subclinical phase of reduced cognitive func-
tion precedes the appearance of diagnosed Alzheimer’s
disease by at least 10 years (1). To postpone or prevent
cognitive decline and even dementia in old age, intervention
during middle age may be required. Lifestyle factors, such as
cigarette smoking and alcohol drinking, are suitable for
interventions targeted to the individual or the community.
There are a number of cross-sectional and longitudinal
epidemiologic studies on smoking, drinking, and cognitive
function in the elderly (2–18). In the majority of the most
recent ones, current smoking was associated with reduced
cognitive function, whereas moderate alcohol consumption
seemed to be related to better cognitive function. Informa-
tion on these associations in middle age is scarce, however
(19). Furthermore, it is still unclear whether the association
between alcohol consumption and cognition is different for
men and women (14, 18) and whether the protective effect is
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limited to subjects with atherosclerosis or cardiovascular
disease (9). In addition, most previous studies used rather
crude instruments for measuring cognitive function.
In the current study, we examined cigarette smoking and
alcohol consumption in relation to several different cogni-
tive domains in a population-based sample of men and
women, the majority of whom were middle-aged, who
participated in a longitudinal population-based study. The
cognitive tests used have been developed specifically for use
in healthy middle-aged and elderly subjects (20, 21).
MATERIALS AND METHODS
Study population
Data were derived from the Monitoring Project on Cardio-
vascular Disease Risk Factors (MORGEN) study, a prospec-
tive study of Dutch adults aged 20–60 years living in
Amsterdam, Maastricht, and Doetinchem (22). The current
study was limited to subjects aged 45 years or older living in
one of these study areas, Doetinchem, a small town of
approximately 40,000 inhabitants located in a rural eastern
area of the Netherlands. The MORGEN study was designed
to monitor levels of and trends in major cardiovascular risk
factors and lifestyle factors and their relation to chronic
diseases. The MORGEN study’s baseline examinations took
place between 1987 and 1991. Each year, a new random
sample was drawn from the civil registry stratified by age (5-
year age classes) and sex. In Doetinchem, 12,668 subjects
participated, and the overall response rate was 62 percent (68
percent for those older than age 45 years). A substantial
proportion of the nonresponse in this study (about 10
percent) may have been due to errors in the civil registry and
to the fact that people had moved away from the area since
the address data had been obtained. Response rates were
higher for women than for men and were also higher for
respondents in the older age categories. There was no
substantial selection by educational level (23).
From 1993 until 1997, a 6-year follow-up examination of
participants who were seen between 1987 and 1991 was
conducted in Doetinchem. The response rate at follow-up for
subjects aged 45 years or older, that is, those who were
eligible for cognitive testing, was 71 percent. Measurements
were similar to those obtained at the baseline examinations.
Again, from 1998 onward, a second follow-up examination
was begun, identical to the first follow-up. Cognitive func-
tion was measured once in each participant from 1995 until
2000, so cognitive testing was spread over several rounds of
follow-up. Risk factors assessed approximately 5 years prior
to cognitive testing were used.
The study was approved by the Medical Ethics Committee
of the Organization for Applied Scientific Research-Zeist.
All participants signed an informed consent.
Assessment of exposure 
For all examinations, participants received a self-
administered questionnaire at home and were invited to
come to a research center for medical examinations. The
questionnaire contained items on demographic variables,
lifestyle factors, (family) history of diseases, and medication
use and was checked at the research center by trained
personnel. Smoking status was assessed with a standard
questionnaire asking about the average number of cigarettes
smoked and the duration of smoking. Cigarette smoking at
baseline (i.e., approximately 5 years prior to cognitive
testing) was classified as current, former, or never. The
number of pack-years was calculated as the average daily
number of cigarettes smoked divided by 20 and multiplied
by the number of years of smoking. Alcohol consumption
was measured with a standardized questionnaire as the
number of drinks (equivalent to a glass of wine) per day of
beer, wine, fortified wine types (i.e., port, sherry), or spirits.
To allow for a possible nonlinear relation between alcohol
and cognitive function, alcohol consumption was grouped
into six categories according to those used by Elias et al.:
nondrinkers, drinking ≤1 drink/day, >1 to ≤2 drinks/day, >2
to ≤4 drinks/day, >4 to ≤8 drinks/day, and >8 drinks/day
(18).
Assessment of cognitive function
Cognitive function was assessed in subjects aged 45–70
years at the time of cognitive testing (85.5 percent were aged
<65 years) by using a neuropsychological test battery that
measures specific cognitive domains, including memory
function, speed of cognitive processing, cognitive flexibility
(the time needed for higher order information processing),
and global cognitive function (21, 24). Included were the
(Visual) Verbal Learning Test, the Concept Shifting Task, an
abbreviated Stroop Color Word Test consisting of three
subtasks, the Letter Digit Substitution Test, and a Word
Fluency Test, in which as many animals as possible had to be
named in 60 seconds. The Stroop Color Word Test consisted
of three cards: I, color names; II, colored patches; and III,
color names printed in incongruously colored ink. The
amount of time needed to read (card I and III) or to name
(card II) colors was recorded. In the Concept Shifting Task,
16 small circles were grouped in a larger circle on each test
sheet. In the smaller circles, the test items (1, 2, 3, . . . ; A, B,
C, . . . ; and 1, A, 2, B, 3, C, . . . ) appeared in a fixed, random
order. Subjects were requested to cross out the items in the
correct order. The time needed to complete the tasks was
recorded. A detailed description of these tests can be found
elsewhere (20, 21). These tests are sensitive to calendar age,
including the middle age range, and have no ceiling effect. In
addition, they are robust in detecting age-related impair-
ment, even at middle age, and are sensitive to subcortical
dysfunction (25). They have also been used in other large-
scale studies on cognitive function (24, 26).
Cognitive tests were carried out by trained investigators
and took about 20 minutes to complete. We measured cogni-
tive function from November 1995 until May 2000 (because
of a lack of time, the Concept Shifting Task was deleted
from the battery from January 2000 onward). In total, 1,927
subjects performed the cognitive tests (1,667 subjects
completed the Concept Shifting Task).
The timed tests (Stroop Color Word Test and Concept
Shifting Task) were log transformed first, because they were
not normally distributed. Raw data were made comparable
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by transforming them into a standardized z score (the differ-
ence between each test score and the average score, divided
by the standard deviation of that score). We calculated
compound scores for psychomotor speed by averaging the z
scores of the 0, A (numbers), and B (letters) versions of the
Concept Shifting Task and subtask I of the Stroop Color
Word Test (complete data were available for 1,639 subjects)
(21). To calculate a compound score for memory function,
the z scores of the total, maximal, and delayed recall scores
of the Verbal Learning Test were averaged (n = 1,906). For
cognitive flexibility or complex speed, the average of the z
scores of the C-version (alternating numbers and letters) of
the Concept Shifting Task and subtask III of the Stroop
Color Word Test was calculated (n = 1,635). As a reflection
of global cognitive function, the average of the z scores of
subtask III of the Stroop Color Word Test, the Letter Digit
Substitution Test, the Word Fluency Test, and the total and
the delayed recall score of the Verbal Learning Test was
calculated (n = 1,886).
In case of problems in assessing cognition, a code was
given for a subject’s lack of motivation in completing the
questionnaire, presence of physical or cognitive limitations,
illiteracy, and deviation from the instructions and for tech-
nical problems. The most frequent problem encountered was
the presence of physical or cognitive limitations (including
dyslexia). The percentages of complete and reliable tests
ranged from 95.9 percent for the Concept Shifting Task to
98.8 percent for the Word Fluency Test. Exclusion of
subjects for whom problems were found during assessment
of the cognitive tests did not alter the results, so it was
decided to retain these subjects for analysis.
Other measurements
Education was assessed as the highest level achieved and
was classified into five categories: primary school, junior
(vocational) education, secondary (vocational) education,
vocational college, and university. Self-reported history of
myocardial infarction, cerebrovascular accident, and
diabetes was recorded at the time of cognitive testing. Phys-
ical activity of at least a moderate level (hours/week) was
also assessed during cognitive testing with an extended
version of a validated physical activity questionnaire (27).
All other possible confounders were assessed at baseline (5
years prior to cognitive testing). Height and weight were
measured during a physical examination at the research
center. Body mass index was calculated as weight (kg)
divided by height (m) squared. Blood pressure was measured
twice at the left arm with a random-zero sphygmomanometer
while the subject was seated. For the analyses, the average of
the two blood pressure measurements was taken.
Nonfasting blood samples were obtained by using a stan-
dardized protocol. Plasma total and high density lipoprotein
(HDL) cholesterol and glucose were determined at the Clin-
ical Chemistry Laboratory of the University Hospital
“Dijkzigt” in Rotterdam, which is the Lipid Reference Labo-
ratory for standardized cholesterol determinations in the
Netherlands. Total cholesterol was determined enzymati-
cally by using a Boehringer test kit (28). HDLs were deter-
mined after precipitation of apolipoprotein-B–containing
lipoproteins with magnesium phosphotungstate (29).
Random glucose levels were measured by using the hexoki-
nase method.
Statistical analysis
To calculate age- and education-adjusted average test
scores for all cognitive tests by smoking status, analysis of
covariance was used. The average of Stroop Color Word
Test subtasks I and II and of Concept Shifting Task versions
A and B was taken. We performed multiple linear regression
analyses in which each regression coefficient represented the
difference in the standardized cognitive score (z score) for
the five alcohol consumption groups relative to the
abstainers and for former and current smokers relative to
never smokers. In addition, subjects who smoked for >0–20
pack-years and >20 pack-years were compared with never
smokers by including two dummy variables in the regression
model. Confounders that were taken into account were age
(continuous), sex, education (four dummy categories), body
mass index, total cholesterol level, and systolic blood pres-
sure. In addition, the alcohol analyses were adjusted for ciga-
rette smoking, and vice versa. In a subanalysis, we also
adjusted for HDL cholesterol, random glucose levels, and
physical activity. To test for a linear trend, the alcohol cate-
gories were entered into the model as a linear term. To
examine nonlinearity, the quadratic term of daily alcohol
consumption was entered into the model. Furthermore, we
checked whether age (dichotomized at 65 years), sex, or a
history of cardiovascular disease modified the associations
by adding interaction terms in the models and by stratifica-
tion. We repeated the analyses after excluding alcohol
abstainers and using the lightest drinking group as reference,
to investigate whether former heavy drinkers influenced the
results. The SAS computer package was used for all statis-
tical analyses (version 8.1; SAS Institute, Inc., Cary, North
Carolina).
RESULTS
Thirty percent of the men and 26 percent of the women
were current smokers (table 1). Smokers were younger and
more often had only a primary school education. The
average numbers of pack-years of smoking were 22.3 (stan-
dard deviation, 13.5) for current smokers and 14.0 years
(standard deviation, 14.5) for former smokers. Twenty-two
percent of the men and 48 percent of the women were
alcohol abstainers. Men were more often categorized in the
moderate and heavy drinking groups, whereas women were
more frequent in the lightest drinking group. All means of
the compound scores for the different cognitive domains
were, by definition, zero.
Cigarette smoking
Table 2 shows the age- and education-adjusted mean
scores for the separate variables of the cognitive tests by
smoking status. Current smokers scored significantly worse
on the Verbal Learning Test and on the Stroop Color Word
Test. Test scores of subjects who formerly smoked seemed
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to be in between those of smokers and never smokers.
Multiple linear regression analyses showed that current
smokers had reduced psychomotor speed (beta = –0.159, p =
0.0003) and reduced cognitive flexibility (beta = –0.133, p =
0.008) compared with never smokers (table 3), which was
similar to the effect of being 3.5–4.5 years older. We found
no interaction between sex and smoking status in relation to
cognitive function. Additional adjustment for a history of
cardiovascular disease did not attenuate the associations. A
dose-response relation seemed to be present as well; for
those subjects who smoked for ≤20 pack-years, the differ-
ence in the psychomotor speed score compared with never
smokers was –0.078 (p = 0.06), whereas for those who
smoked for >20 pack-years, the difference was –0.141 (p =
0.004). For the association with flexibility, these differences
were –0.053 (p = 0.25) and –0.133 (p = 0.02), respectively.
The relation between pack-years and speed and flexibility
was similar among current and former smokers.
Alcohol consumption
The association between alcohol consumption and the
timed tasks—psychomotor speed and flexibility—was
slightly U-shaped, with significant p values for the quadratic
term (p = 0.001 and p = 0.01, respectively) (figure 1).
Subjects who drank between 1–2 and 2–4 alcoholic bever-
ages per day performed significantly better on these tests.
Surprisingly, subjects who drank >8 glasses of alcohol per
day performed better on the memory subtasks compared
with abstainers. However, this group was very small (n = 7)
and consisted of men only. Average alcohol consumption in
this group was 10 drinks/day, with a maximum of 12.9
drinks/day. Alcohol consumption was not associated with
overall cognition. There was a significant interaction between
sex and alcohol consumption in relation to speed (p = 0.008),
indicating that, for women, the association between alcohol
consumption and psychomotor speed was positive and linear
(p-trend < 0.001), whereas for men it was absent (table 4).
The association with cognitive flexibility was stronger
among women as well, although the interaction term was not
significant. When we excluded the abstainers and used the
lightest alcohol consumption group as the reference, results
were not altered.
Additional adjustment for other possible confounders or
for cardiovascular disease as a mediating factor did not
change the results. No interaction with age or cardiovascular
disease was found, suggesting that the associations were
similar in those younger and those older than age 65 years at
the time of the cognitive tests and in those with and those
without a history of cardiovascular disease. Finally, we
conducted the analyses again after excluding subjects who
scored in the lowest 5 percent of the overall cognitive index
and of the memory subscale, which did not alter the results.
TABLE 1.   Baseline characteristics of men and women studied 
regarding the relation of cigarette smoking and alcohol 
consumption to cognitive performance in middle age, 
Monitoring Project on Cardiovascular Disease Risk Factors, 
the Netherlands, 1995–2000
* SD, standard deviation.
† At the time of cognitive testing.
Men
(n = 905)
Women
(n = 989)
Mean age (years) (SD*)† 56.6 (7.1) 56.2 (7.1)
Education (% primary school 
only) 9.8 13.0
Smoking status (%)
Never smoker 22.7 41.8
Former smoker 47.6 31.9
Current smoker 29.7 26.4
Alcohol consumption (glasses/
day) (%)
0 21.6 47.9
≤1 24.5 29.2
>1 to ≤2 22.1  15.3
>2 to ≤4 23.2 6.4
>4 to ≤8 7.9 1.2
>8 0.8 0
Body mass index (kg/m2) (SD) 26.0 (3.0) 25.6 (4.0)
Total cholesterol (mmol/liter) 
(SD) 5.80 (1.01) 5.81 (1.05)
Systolic blood pressure (mmHg) 
(SD) 128.7 (16.2) 122.6 (17.0)
History of vascular disease (%)† 5.8 3.4
FIGURE 1. Adjusted beta coefficients reflecting the difference in
the standardized scores (one unit of the cognitive score = one stan-
dard deviation) for different cognitive domains according to alcohol
consumption categories, Monitoring Project on Cardiovascular Dis-
ease Risk Factors, the Netherlands, 1995–2000. Beta coefficients
were adjusted for age, sex, education, body mass index, total choles-
terol, systolic blood pressure, and cigarette smoking. d, day.
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DISCUSSION
This population-based study of mostly middle-aged
subjects showed that current smoking and number of pack-
years of smoking were related to reduced performance on
tests of psychomotor speed and cognitive flexibility assessed
approximately 5 years later. The association between past
alcohol consumption and speed and flexibility appeared to
be slightly U-shaped, with the best performance among
those who drank between one and four glasses of alcohol per
day, and the association was stronger for women than for
men. Observed relations were independent of differences in
age, education, and several cardiovascular risk factors.
Methodological considerations
The strength of our study was the use of a cognitive battery
that included tests sensitive to small cognitive changes even
in middle age. We decided to investigate cognitive function
as a continuous instead of a binary measure (cognitive
impairment vs. normal cognition), since clinically signifi-
cant cognitive deficits are less frequent among the middle-
aged and because analyzing the cognitive scores continu-
ously yielded more power. In middle age, cognitive function
is still relatively well preserved. Therefore, it is not very
likely that exposure assessment was influenced by reduced
cognitive function. The possibility does exist that subjects
with cognitive impairment were already cognitively
impaired 5 years previously and, as a result, changed their
smoking and drinking habits. However, when we excluded
subjects whose cognitive scores were in the lowest 5 percent,
the results were essentially the same.
A limitation of our study is that cognitive function was
measured only once. It would have been more informative to
have data on change in cognitive function after smoking and
drinking were assessed. Furthermore, response rates were
moderate, but there was no evidence of selective participa-
tion. Nevertheless, one can imagine that heavy drinkers and
subjects with severe cognitive impairment were underrepre-
sented, possibly resulting in underestimation of the associa-
tion between heavy drinking and cognitive impairment.
Finally, we had no information on drinking history.
Abstainers may have included formerly heavy drinkers and
subjects who quit drinking because of an illness. Their risk
of cognitive impairment will be different from that of life-
time abstainers. When we excluded the abstainers and used
the lightest drinking group as the reference, though, the
results were essentially the same.
Previous studies
Most previous studies investigating the association
between smoking and cognitive function focused on older
subjects and were cross-sectional. The majority found that
current smoking was related to reduced cognitive function
(2–7), and a dose-response relation with amount smoked has
been observed (8). There are a number of longitudinal
studies on this topic. They also showed that smoking
increased the risk of cognitive decline or cognitive impair-
ment (6, 9–11), although, in the East Boston, Massachusetts,
study, no consistent association was observed between
smoking and cognitive decline (13).
Cross-sectional studies on alcohol consumption and cogni-
tive impairment among the elderly have demonstrated an
inverse association (4, 8, 14, 15), an inverted U-shaped asso-
ciation (16), or no clear association (2). In the Epidemiology
of Vascular Aging (EVA) Study, an inverse association
TABLE 2.   Adjusted† mean scores on the cognitive tests, by smoking status, Monitoring Project on Cardiovascular Disease Risk 
Factors, the Netherlands, 1995–2000
* p < 0.05 for difference with never smokers.
† Adjusted for age and education.
‡ CI, confidence interval.
§ Minus the no. of seconds needed for the zero version of the Concept Shifting Task.
Never smokers
(n = 618)
Former smokers
(n = 746)
Current smokers
(n = 530)
Mean 95% CI‡ Mean 95% CI Mean 95% CI
Verbal Learning Test
Best trial (no. of words) 10.4 10.2, 10.5 10.1 9.9, 10.2* 10.1 9.9, 10.3*
Delayed recall (no. of words) 8.2 8.0, 8.4 7.9 7.7, 8.1 7.9 7.7, 8.2
Concept Shifting Task
A + B version (average in seconds)§ 18.4 17.8, 18.9 18.8 18.3, 19.3 18.9 18.3, 19.4
C version (seconds)§ 30.5 29.4, 31.5 30.7 29.6, 31.7 30.7 29.6, 31.9
Stroop Color Word Test
Subtasks I and II: reading and naming (average in 
seconds)
18.8
18.5, 19.0
19.1
18.9, 19.4
19.5
19.2, 19.8*
Subtask III: interference (seconds) 44.2 43.0, 45.4 45.5 44.4, 46.6 46.5 45.2, 47.7*
Letter Digit Substitution Test (no. of letters/minute) 32.3 31.8, 32.8 32.1 31.6, 32.5 31.7 31.2, 32.2
Word Fluency Test (no. of animals/minute) 23.7 23.3, 24.1 23.4 23.0, 23.8 23.8 23.4, 24.3
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between alcohol consumption and cognitive impairment was
primarily present among female participants, which is in
agreement with our results (14). Past alcohol consumption
was associated with either an increased (5) or a decreased
(17, 18) risk of cognitive impairment several years later.
Results from longitudinal studies that included two assess-
ments of cognitive function were inconsistent. Some found
no relation between alcohol consumption and cognitive
TABLE 3.   Adjusted beta coefficients reflecting the difference in the standardized score† for several 
cognitive domains, according to smoking status, Monitoring Project on Cardiovascular Disease Risk 
Factors, the Netherlands, 1995–2000
* p < 0.05.
† One unit of the cognitive score = one standard deviation.
‡ Adjusted for age, sex, education, body mass index, total cholesterol, systolic blood pressure, and alcohol
consumption.
§ Additional adjustment for a history of cardiovascular diseases (myocardial infarction, stroke, or diabetes).
¶ CI, confidence interval.
Model I‡ Model II§
Beta 
coefficient 95% CI¶
Beta 
coefficient 95% CI
Cognitive index (range, –1.9 to 1.6)
Former vs. never smokers –0.019 –0.071, 0.034 –0.017 –0.070, 0.035
Current vs. never smokers –0.005 –0.063, 0.052 –0.003 –0.060, 0.055
Memory (range, –3.0 to 2.5)
Former vs. never smokers –0.012 0.085, –0.108 –0.009 0.085, –0.103
Current vs. never smokers –0.040 0.062, –0.143 –0.035 0.067, –0.138
Speed (range, –2.0 to 4.8)
Former vs. never smokers –0.059 0.021, –0.139 –0.058 0.023, –0.138
Current vs. never smokers –0.159* –0.071, –0.244 –0.157* –0.070, –0.244
Flexibility (range, –3.0 to 4.0)
Former vs. never smokers –0.041 0.048, –0.131 –0.040 0.050, –0.103
Current vs. never smokers –0.133* –0.035, –0.230 –0.130* –0.032, –0.227
TABLE 4.   Adjusted† beta coefficients reflecting the difference in the standardized score‡ for several cognitive domains, according 
to alcohol drinking categories,§ among men and women, Monitoring Project on Cardiovascular Disease Risk Factors, the 
Netherlands, 1995–2000
* p < 0.05.
† Adjusted for age, sex, education, body mass index, total cholesterol, systolic blood pressure, and cigarette smoking.
‡ One unit of the cognitive score = one standard deviation.
§ Reference, no alcohol consumption.
¶ CI, confidence interval.
Category (no. of drinks/day)
p-
trend
p-
quadratic
≤1 1 to ≤2 2 to ≤4 4 to ≤8 >8
Beta 
coefficient 95% CI¶
Beta 
coefficient 95% CI
Beta 
coefficient 95% CI
Beta 
coefficient 95% CI
Beta 
coefficient 95% CI
Cognitive 
index
Men 0.030 –0.061, 0.121 –0.062 –0.156, 0.032 0.026 –0.068, 0.120 0.028 –0.105, 0.161 0.241 –0.120, 0.600 0.66 0.47
Women 0.026 –0.043, 0.095 –0.004 –0.093, 0.085 0.154* 0.027, 0.281 0.133 –0.135, 0.401 0.08 0.84
Memory
Men 0.084 –0.077, 0.245 –0.101 –0.267, 0.065 0.058 –0.109, 0.225 0.080 –0.155, 0.315 0.672* 0.032, 1.312 0.48 0.25
Women 0.054 –0.071, 0.179 –0.015 –0.176, 0.146 0.190 –0.040, 0.420 0.107 –0.379, 0.593 0.28 0.94
Speed
Men –0.045 –0.190, 0.101 0.097 –0.050, 0.244 0.055 –0.092, 0.203 0.039 –0.166, 0.245 –0.041 –0.613, 0.532 0.28 0.13
Women 0.125* 0.024, 0.226 0.216* 0.086, 0.346 0.347* 0.160, 0.534 0.461* 0.096, 0.826 <0.001 0.08
Flexibility
Men 0.024 –0.134, 0.182 0.120 –0.040, 0.280 0.156 –0.005, 0.317 0.102 –0.122, 0.326 0.097 –0.523, 0.717 0.05 0.04
Women 0.143* 0.026, 0.260 0.163* 0.013, 0.313 0.277* 0.060, 0.494 0.034 –0.389, 0.457 0.006 0.10
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decline (9, 11, 13), whereas one found that abstinence from
alcohol was a baseline predictor of poor cognitive outcome
(12).
Very few studies have been conducted among middle-
aged subjects. The Atherosclerosis Risk in Communities
(ARIC) study investigated the cross-sectional relation
between smoking, drinking, and cognitive function among
subjects aged 45–69 years (19). Current smokers performed
worse on the Digit Symbol Substitution Subtest and the
Delayed Word Recall. Furthermore, a positive association
was found between alcohol drinking and the Word Fluency
Test, and an inverted U-shaped relation was found with the
Digit Symbol Substitution Subtest and the Delayed Word
Recall. These results are comparable to those from our study.
In a cross-sectional study among subjects aged 24–81 years,
no association between smoking, alcohol consumption, and
similar measures of cognitive function could be identified
(30).
Possible mechanisms
In our study, the cognitive domains affected—psycho-
motor speed and cognitive flexibility—may suggest subcor-
tical dysfunction, which can be the result of subcortical
small-vessel lesions. Speed of mental processing in partic-
ular has been related to white matter changes (24, 31). Thus,
a vascular mechanism for the observed associations seems
likely. Smoking is a risk factor for stroke and has also been
associated with vascular dementia (32, 33). Cerebral vasodi-
latation and vasoconstriction response and cerebral blood
flow was lower in the cerebral vessels of smokers (34),
which could be improved by quitting smoking (35). These
changes could lead to large and small infarcts, resulting in
reduced cognitive function. Cerebral blood flow has also
been directly related to cognitive performance (36).
The relation between alcohol consumption and cognitive
function appeared to be slightly U-shaped, which is similar
to the shape of the observed association of alcohol consump-
tion with cardiovascular disease and atherosclerosis (37–39).
This association may be mediated by beneficial effects of
alcohol on lipid levels (38, 40), lipoprotein(a) levels (41),
insulin sensitivity (42), plasma concentration of endogenous
tissue-type plasminogen activator (43), plasminogen acti-
vator inhibitor type 1 (44), prostacyclin levels (45), and
fibrinogen levels and fibrinolytic activity (46). The positive
effect could also be mediated by flavonoids in red wine,
which has antioxidant properties (47). In addition, alcohol
consumption leads to increased cerebral blood flow (48),
which is associated with better cognitive performance (36).
In contradiction to the more acute effects of alcohol on cere-
bral blood flow, subjects with chronic alcoholism were
found to have reduced cerebral blood flow and consequently
reduced cognitive function (49, 50). Adjustment for a history
of cardiovascular disease or diabetes did not attenuate the
associations between alcohol consumption, cigarette
smoking, and cognition. However, these diseases do not
fully reflect subclinical atherosclerosis and small-vessel
disease in the brain, which may be a stronger intermediate
factor. Unfortunately, we were not able to adjust for more
direct indicators of these vascular conditions.
Chronic and heavy alcohol consumption is neurotoxic and
may lead to the Wernicke-Korsakoff syndrome, which is
characterized by severe memory impairment. In our study,
we did not find an adverse relation between the highest
drinking group and cognitive function, but drinking levels in
this group were not extremely high. In addition, subjects in
the highest drinking group were slightly younger and were
relatively highly educated. Adjustment for these risk factors
did not alter the results. A previous study also found that
patients with chronic alcoholism had normal cognitive
performance, whereas patients with Korsakoff’s syndrome
had performance deficits on several cognitive domains (51).
Among women compared with men, we observed a
stronger relation between moderate alcohol consumption
and some aspects of cognition, as was also found in some
other studies (2, 5, 14, 18). Alcohol consumption levels are
different for men and women, that is, there were no women
in the highest alcohol consumption group, but the same cate-
gories were used for both sexes. Furthermore, women who
drink alcohol may have different risk factor behavior and
may have a higher socioeconomic status than men who drink
alcohol. Moderate alcohol consumption may be regarded as
a proxy for outgoing and social behavior, which could be
related to better cognitive function. We adjusted for many
potentially confounding factors, but perhaps some residual
confounding remained. The divergent results may also be
due to sex differences in alcohol metabolism (52). The
effects of alcohol on HDL cholesterol, blood pressure, and
peripheral artery disease, for example, seem to be different
in men and women (53–56). In general, women are more
vulnerable to the adverse effects of alcohol (57). Therefore,
the presence of a predominant protective effect of moderate
alcohol consumption on cognition among women is unex-
pected. However, it may be that women are more susceptible
to not only the adverse effects but also the protective effects
of alcohol.
Conclusion
This study showed that common risk factors that have
been associated with cognitive decline in old age already
lead to a subtle reduction in cognitive function in middle age.
The effects of cigarette smoking and alcohol consumption on
cognition found in this study were small and, for most
people, probably not even noticeable, but they were compa-
rable to the effects of being approximately 4 years older. We
expect that, at later ages, the cognitive disturbances among
those who continue to smoke will become more pronounced
and clinically important. Therefore, community interven-
tions regarding these common risk factors in middle age may
have a large impact on cognitive decline in old age.
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